Sionna Therapeutics is trading 6.39% up at $7.49, supported primarily by stronger risk appetite as major U.S. indexes rise and biotechnology stocks rally.
- Rebounding from the September 15 selloff and September 16 close of $7.04.
- XBI is up 2.55%.
- No fresh company-specific announcement was identified for September 17, 2026; the September 14 Phase 2a combination-trial plan remains background, not a new catalyst.